Microemulsions combine the advantages of emulsions with those of nanocarriers, overcoming the stability problems of the former and providing facile scalable systems with compartments adequate for high drug loadings. Recently, microemulsions are gaining attention in the formulation of anticancer drugs not only for topical treatment, but also for systemic delivery as well as for the development of theranostic systems. The aim of this paper is two-fold. First, an updated review about general features, preparation, characterization and pharmaceutical applications, with a special focus on colorectal cancer, is provided. Second, a case study of formulation of methotrexate in microemulsions is presented. Various essential oils (menthol, trans-anethole, α-tocopherol) and surfactants (TPGSl000, Maxemul 6112, Noigen RN-20) were investigated for the preparation of o/w microemulsions for the delivery of methotrexate, and the ability of methotrexate-loaded microemulsions to inhibit cancer cell growth was then evaluated. Disregarding the surfactants used, menthol and trans-anethole led to cytotoxic microemulsions, whereas α-tocopherol based-formulations induced cell proliferation. These findings highlight the role that the oily component may play in the efficacy and safety of the microemulsions.
Combination of the above mentioned advantages while maintaining the capacity to solubilize hydrophobic drugs explains that microemulsions occupy a relevant position among other nanometric carriers [7, 8] . It should be noted that compared to conventional and reverse micelle systems, the inner compartment of microemulsion droplets is notably larger and so is its capability to host larger amounts of drugs and even therapeutic macromolecules.
Depending on the ratios between the components, three main types of microemulsions can be prepared. When the content in water is large, microemulsions consist of small oil droplets surrounded by an interfacial film of both surfactant and co-surfactant molecules and dispersed in the aqueous phase (o/w microemulsions). Oppositely, if the content in water is low, the situation is reversed and the system consists of water droplets dispersed in oil (w/o microemulsions). Those systems that exhibit a gradual transition from o/w to w/o microemulsion are known as bicontinuous microemulsions [9] . Since the 2000s, U-type microemulsions are receiving increasing attention [10] . These are highly water dilutable microemulsions that change progressively upon water addition from w/o to o/w without phase change [11] .
Droplets in the microemulsions can adopt spherical (o/w, w/o) or tubular morphologies, depending on the magnitude of the surfactant packing parameter, v/(a o lc), where v is the volume occupied by the hydrocarbon tail of the surfactant, a 0 is the area of the polar head and lc is the length of the totally extended hydrocarbon chain of the surfactant [12] [13] [14] . In this mini-review, the focus will be on o/w microemulsions with spherical droplets. Following the concept of the packing parameter it is found that when a 0 > v/lc, then an o/w microemulsion forms; if a 0 < v/lc, then a w/o microemulsion is obtained, and if a 0 ≈ v/lc, then a middle-phase (bicontinuous) microemulsion is the preferred structure [13] .
Microemulsion formation is a spontaneous process, as indicated by a negative Gibbs free energy of formation, ΔG. For microemulsions, the equation can be written as: ΔG = γΔA  TΔS where γ is the interfacial tension, ΔA the change in interfacial area during the formation process, ΔS the change in entropy and T is the temperature. Microemulsion formation is accompanied by a significant increase in the interfacial area, A. In as much as the interfacial tension γ decreases notably (but remains positive all the time), a negative free energy is attained when the interfacial energy (γA) is compensated by a dramatic change in the dispersion entropy of the system [15, 16] . A very low interfacial tension required for microemulsion formation cannot always be accomplished by the selected surfactant and sometimes a co-surfactant is required. The co-surfactant penetrates the amphiphilic interfacial layer, and increases its curvature and fluidity [16, 17] . For this purpose and for reasons of biocompatibility, preferably non-ionic surfactants and short or medium chain alcohol s are used [8, 15, 16] .
Phase equilibria in microemulsions can be studied through the construction of phase diagrams at a given temperature. In its simplest form, the diagram includes the proportions of oil, water and surfactant mixtures, and shows the combinations that lead to a single (apparent) phase [18] . A well-known classification of microemulsions is that of the Winsor type systems [19] . A Winsor I system consists of two phases, in which the o/w microemulsion phase placed at the bottom is in equilibrium with the supernatant oil in excess. Winsor II system comprises two phases also, but the upper microemulsion phase (w/o) is in equilibrium with excess water. Winsor III systems are characterized by the coexistence of three phases: the microemulsion (o/w plus w/o, also known as bicontinuous) located in between oil (upper phase) and water (lower phase). Winsor IV systems exhibit a single phase domain, with oil, water and surfactant homogeneously mixed (microemulsion). These systems are schematically represented in (Fig. 1) .
Fig. (l).
Winsor classification of microemulsion systems [19] .
Microemulsions Preparation
Preparation of a microemulsion to be used as drug nanocarrier system requires a careful selection of both qualitative and quantitative composition. The components should be chosen to fit the biocompatibility demands of the administration route and, therefore, adverse reactions and sensitizing or irritation potential of each compound have to be carefully considered. Moreover, the components should have adequate physicochemical properties, mainly regarding melting point, viscosity, chemical stability, ionization degree, and pH. On the other hand, the formation of thermodynamically stable microemulsions requires an adequate amount of the components to be mixed. As mentioned above, an important tool to correctly choose the compositions is the elaboration of ternary or pseudoternary phase diagrams.
Components
Oil phase. Most microemulsions performing as drug nanocarriers are o/w systems and, consequently, the main criterion that the oil phase must accomplish is that the drug should have high solubility in it. The oil also affects the curvature of the microemulsion droplet, as this depends on the ability of the surfactant tails to penetrate and swell in the interface. Since the drug delivery system should be biocompatible, excipients to be used in the formulation are restricted to some natural oils (com, cottonseed, orange, clove, peppermint, eucalyptol, coconut, soybean and jojoba oils) [20] [21] [22] [23] [24] , triglycerides and esters of fatty acids (e.g., isopropyl myristate (IPM), ethyl oleate) [25] [26] [27] .
Aqueous phase. It usually contains regulators of pH (buffers) and ionic strength (salts) as well as certain cosolvents (mainly alcohols).
Surfactants
The role of the surfactant in the formulation is to lower the interfacial tension between oil and water as much as possible in order to facilitate the spontaneous formation of the microemulsion and to provide mechanical flexibility to the droplets. The surfactant should have the appropriate lipophilic character to give the correct curvature at the interfacial region. The emulsifying capability of an agent may be classified according to the hydrophilic-lipophilic balance (HLB) in its molecule. This is a function of the weight percentage of hydrophilic groups in the molecule [28] . Generally low HLB (< 12) surfactants lead to w/o microemulsions, while high HLB (> 12) ones are mostly suitable for o/w microemulsions. Commonly used surfactants are Aerosol OT and non-ionic molecules, such as polysorbates, alkyl polyethers, and sorbitan monoesters [29] . Surfactants are commonly included at proportions as high as 25% and, therefore, they should be carefully chosen to avoid toxicity problems when administered through a given route. In general, surfactants cannot be assumed to be inert excipients since they can modify the transfer of drugs across biological membranes. Further, surfactants might produce significant changes in the biological activity of drugs by exerting an influence on metabolizing enzymes or on the binding to receptor proteins [30] .
Co-surfactants
They are short to medium chain length alcohols or amines (C3-C8) that reduce the interfacial tension and increase the fluidity of the interface [29, 31] . Both surfactants and co-surfactants migrate to the liquid-liquid interface, which helps to decrease more the interface tension.
Drugs
Commonly the drug is incorporated to the inner oil phase, but if the drug is oily, it may constitute itself the inner phase. Hydrophilic drugs could be also dissolved in the aqueous phase, and the microemulsion could allow formulating together immiscible/incompatible drugs or may enable a rapid release of the drug from the aqueous phase and a sustained release of the drug incorporated into the oil phase.
Preparation Methods
There are two main methods to prepare microemulsions, as described below.
Phase Titration Method
First a ternary or pseudoternary diagram is constructed. Each comer represents 100% of a particular component, as shown in (Fig. 2) . The regions can be separated into w/o or o/w microemulsions by simply considering whether it is oil rich or water rich. If only water and surfactant predominate, conventional micelles are formed. Oppositely, the surfactant molecules arrange in the form of reverse micelles if oil and surfactant are the major components.
Phase Inversion Method
lt consists in increasing the temperature to cause loss of water of the head groups of the surfactants [32] . Shrinking the head group area of the non-ionic surfactant causes a phase inversion from o/w to w/o microemulsions in two-phase mixtures with either excess oil or excess water (phase inversion temperature, PIT) [33] . The changes in the curvature of non-ionic surfactant packing force a transition from an o/w microemulsion at low temperature to a w/o microemulsion at higher temperature (transitional phase inversion) [34] . Alternatively, phase inversion can occur adding the dispersed phase in excess. Phase inversion is accompanied by marked changes in physical properties including droplet size.
Microemulsions Characterization
The characterization of microemulsions is a difficult task due to their complexity and the variety of structures and components involved in these systems. The starting point is the construction of a ternary diagram (as depicted in Fig. 2 ). More complex and sophisticated techniques are then used to investigate in detail physicochemical properties and their dependence on the composition and variables such as pH or temperature. Some of the techniques most frequently used are electron microscopy, nuclear magnetic resonance, spectroscopy, rheology, electrical conductivity, and radiation scattering.
Scattering techniques involve X-rays, neutrons and light and provide information about droplet size and internal structure. These techniques rely on the application of an incident beam of radiation to the sample, and subsequent registration of the intensity and the angle of the scattered beam. The scattering originates when the radiation interacts with regions of different refractive index (light scattering), electron density (X-ray scattering) or nuclear composition (neutron scattering) [18, 35] . Dynamic light scattering (DLS), quasielastic light scattering and photon correlation spectroscopy have been applied to analyze microemulsion droplet size via determination of the hydrodynamic radius, which can be estimated from measurements of the diffusion coefficients of the dispersed phase (droplets) undergoing Brownian motion. The equipment employed in this technique is rather simple and experimental times are very short [36, 37] . In the small-angle x-ray scattering (SAXS) technique, the scattering profile at low angles is fitted to adequate models to obtain reports about the shape, size and nanostructure of scattering elements; in the case of microemulsions, angles must be lower than 10, because of the scale of study is > 10 nm [18] .
Comprehensive information about characterization techniques can be found in recent reviews [18, 35] and the interested reader is referred to them for details.
Microemulsions as drug delivery systems

Application Field
In the past 20 years, oil-in-water and water-in-oil microemulsions have been intensive1y evaluated as carriers for drug delivery [37] . Microemulsion systems allow sustained or controlled release of drugs for transdermal, topical, oral, nasal, ocular, parenteral and other administration routes [5] . The shelf-life of the microemulsions largely depends on their thermodynamic stability and the chemical stability of the drug in the dispersed phase. Stability in a wide range of temperatures, viscosity sufficiently low to allow filtration sterilization, acceptance of a variety of additives, removal from the application site or c1earance from the body are key factors for the use of these systems in the pharmaceutical field [38, 39] . Most research has focused on applications related to skin therapy and transdermal delivery [40, 41] due to concerns raised by the use of so large amounts of surfactants. Nevertheless, if the composition is adequately tuned, microemulsions can offer important advantages for systemic delivery of drugs.
Since microemulsions possess both polar and non-polar microdomains, it is possible to solubilize both hydrophilic and lipophilic drugs in these microscopically heterogeneous but macroscopically homogeneous systems [27, [42] [43] [44] . Their large content in surfactants al so contributes to the solubilization capability of the microemulsions. In fact, microemulsions can increase up to several orders of magnitude the apparent solubility of drugs considered of Class II of the Biopharmaceutical Classification System (BCS), notably enhancing their oral bioavailability [20, 45, 46] . Encapsulation in the droplets also protects the drug from adverse environments, improving the stability against hydrolytic and oxidative processes. Additionally, since the small droplets can rapidly extend on epithelia (including the gastrointestinal one) and the surfactants can increase cell permeability, microemulsions have been shown to favor the permeability/absorption of a variety of drugs, inc1uding peptides and proteins [47] . Accumulation in intestinal lymph and absorption via the lymphatic route can also play a role in the oral absorption of drugs encapsulated in lipid droplets [48] .
Regarding parenteral delivery, o/w microemulsions have been largely tested as depots of hydrophobic drugs when administered subcutaneously or intramuscularly. A similar role can be played by w/o microemulsions encapsulating hydrophilic drugs. Intravenous administration of hydrophobic antitumoral, antimicrobial and antiinflamatory drugs has been shown to be also notably facilitated when formulated as o/w microemulsions [49] . Microemulsions enable the preparation of liquid formulations (with the drug totally solubilized in the droplets) avoiding the use of ethoxylated castor oil (Cremophor ® EL) which is commonly employed to prepare injectable solutions of hydrophobic therapeutic agents. Additionally, if PEGylated surfactants are used, microemulsions show high physical stability in plasma and great resistance to leaching of drugs through the oil phase, which in turn facilitates a sustained re1ease of the drug in the blood stream [50] [51] [52] . The small size of the microemulsion droplets ensures that the probability of emboli formation in the blood is insignificant and, if the surface is neutral or anionic, a prolonged blood circulation time can be achieved [49] . All together these features make microemulsions attractive for passive targeting of drugs towards tissues showing enhanced capillary permeability, such as those affected by inflammatory, infectious or tumoral processes. Sizes between 10 and 100 nm (which are the typical ones of microemulsion droplets) have been pointed out as the optimum for exploiting the enhanced permeability and retention (EPR) effect [53] . Selective extravasation of drug-loaded droplets can allow for greater accumulation of the drug in the sites of the body where it is required. Therefore, therapeutic efficacy is improved while total systemic dose can be notably diminished [5] . For example, phospholipid-based microemulsions loaded with all-trans-retinoic acid have been proved to be suitable for treatment of patients with acute promyelocytic leukemia [54] . Although much less investigated than other nanocarriers, microemulsion droplets could be al so susceptible of decoration with ligands able to recognize specific cells, enabling active targeting as recently demonstrated for nanoemulsions [55] . Moreover, microemulsions droplets are suitable starting cores for functionalization with diagnostic agents (magnetic resonance imaging (MRI), X-ray computed tomography (CT) imaging) and may lead to theranostic systems [56] .
Drug release rate from microemulsions largely depends on the composition of each specific formulation and on the environmental conditions (e.g., pH, stirring, ionic strength, enzymes). In o/w microemulsions, the oily droplets behave as cores and the lipophilic drugs have to cross the surfactant layer (which may behave as an additional, intermediate phase) and then diffuse towards the aqueous barrier and partition into it [57] . The strength of the interactions between microemulsion components has been shown to play a role in the release rate of ketoprofen and octylmethoxycinnamte [58, 59] . For drugs showing poor affinity for the aqueous environment, drug solubility in the aqueous phase may become the rate limiting step of the release process. If surfactant species are present in the release medium (as occurs when microemulsions are orally administered), interaction of the drug with the surfactants may also play a relevant role in the release process, and profiles typical of diffusion through a thick membrane can be obtained [60, 61] . Temperature has been shown to notably affect the release rate of Vitamins C and E from isopropyl myristate, Tween 80 and Imwitor 308 o/w microemulsions [62] and from isopropyl myristate, Span 20, Tween 20 microemulsions which also incorporated Pluronic FI27 in the aqueous phase [63] .
Microemulsions for Colorectal Cancer Treatments
In the last two decades intensive research has been focused on the formulation of different anticancer drugs as microemulsions. Paclitaxel (PTX), methotrexate (MTX), curcumin (CUC), and doxorubicin (DOX) have been shown to be soluble in a variety of oils (essential and edible) and also to be incorporated with high encapsulation yield in microemulsions [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] . These systems have been tested in different cell lines such as breast, cervical, colon and colorectal cancer cells. In some reports it has been noted that blank microemulsions themselves have certain activity against the cancer cells. Thus, drugloaded microemulsions inhibit cell growth with lower dose of the chemotherapeutic agent. Relevant microemulsions loaded with anticancer drugs that have been successfully employed either in in vitro or in vivo studies are reported in Table 2 . As can be seen in Table 2 most of the surfactants are quite biocompatible (e.g., polysorbates, soya derivatives and lecithin) and may partially or even totally replace Cremophor EL.
Compared to other cancer cells, the studies about the use of microemulsions (loaded or non-loaded with anticancer drugs) for inhibiting the growth of colorectal cancer cells is much limited. Reports in the literature are still scarce. Microemulsions based on 37% Cremophor EL/transcutol mixture 2:1, 29% Capryol 90, and 34% water were loaded with docetaxel and tested in colon cancer cells (HCT-116), [77] Droplets without drug (blank microemulsion) had sizes in the 89±25 nm range, while after loading the size increased up to 205± 13 nm, All microemulsions showed high cytotoxic effects on colon cancer cells compared with the reference Taxotere, but caused less detrimental effects on non-tumoral human epithelial cells. Therefore, docetaxel-loaded microemulsions showed improved therapeutic efficacy and safety [78] . In other work, microemulsions were prepared combining Tween 80, Span 20, ethanol, isopropyl myristate and water and loaded with gemcitabine [78] , a chemotherapeutic agent effective against many solid tumors and also employed in colorectal cancer treatment [79] . Drug-loaded microemulsions had high hemolysis activity (17-21 %) although below that exhibited by a drug solution of similar concentration (37%). Blank microemulsions showed a relevant cytotoxic activity (30-50% growth inhibition) against HCT-116 colon cancer cells. Moreover, cells treated with drug-loaded microemulsions showed more intense apoptosis than those exposed to the drug solution [78] .
Microemulsions have been also shown to be particularly suitable to encapsulate plant extracts whose antitumoral activity is limited by a poor aqueous solubility [80, 81] . For example, Flammulina velutipes sterol (active against gastric and colon cancer cells) was encapsulated in a microemulsion prepared with 0.3% medium chain triglycerides, 5.0% ethanol, 21.0% Cremophor EL and 71.0% water, leading to an apparent solubility of the sterol of three orders of magnitude higher with respect to the solubility in water [80] . lnterestingly, the microemulsion exhibited a good physical stability and no loss of drug was observed in the first 24 hours after 100-fold dilution with distilled water. When orally administered to healthy rats, microemulsions increased more than 2-fold the bioavailability of the sterol. Similarly, quercetin was formulated in a microemulsion prepared with 7% ethyl oleate, 48% Tween 80 and 45% dehydrated ethanol (co-surfactant) [82] . Compared to quercertin-loaded micelles (without ethyl oleate), the microemulsion notably enhanced intestinal absorption of the drug. lnterestingly, site-specific absorption of the drug-loaded emulsion was observed in vivo; the uptake percentage being greater in colon followed by ileum. These findings can be related to the thinner mucous layer of the colon and to the predominance of M cells and lymphatic vessels of ileum.
Formulation of methotrexate microemulsions
In the last part of this paper, a case study of formulation of MTX in microemulsions is presented. The aim was to investigate the suitability of essential oils for the preparation of o/w microemulsions for the delivery of methotrexate and to elucidate the ability to inhibit cancer cell growth.
Materials
Balb 3T3 done A31 mouse embryonic fibroblast cells (CCL-163) and HeLa cervical cancer cells (CCL-2) from American Type Culture Collection (USA). DMEM F12-HAM, RPMI 1640 with and without folic acid, D-α-tocopherol polyethylene glycol 1000 succinate (TPGS-1000), 2-methyl-1-propanol (isobutanol), D-L-α-tocopherol (vitamin E) and trans-anethole from Sigma-Aldrich (Germany); mentha piperita (peppermint) essential oil (menthol main component) from Eladiet (Spain); penicillin/ streptomycin from Hyclone Thermo Scientific (UK), fetal bovine serum (FBS) from Biowest (France), Maxemul 6112 from Croda (UK), Noigen RN-20 from Dai-Ichi Kogyo Seiyaku (Japan), methotrexate (MTX) from AK Scientific (USA), and MTT proliferation Kit from Roche (Germany). Ultrapure MilliQ water was obtained using a Millipore equipment (Spain). Other reagents were analytical grade.
Methods
Preparation of'o/w Microemutsions
Solutions of Maxemul 6112 (10% w/w; anionic surfactant) and TPGS-1000 (10% w/w; non-ionic surfactant) were prepared separately in phosphate buffer pH 7.4 (PBS). Then, isobutanol was added dropwise and magnetic stirring was maintained until the solutions became transparent again. In the case of MTX-loaded microemulsions, fue drug was first dissolved in isobutanol. Following, oil phase was added (compositions in Table 3 ) and the systems were kept under magnetic stirring until the turbidity disappeared. MTX final concentration was 0.3 mg/mL in microemulsions prepared with D-L-α-tocopherol (vitamin E) and 0.6 mg/mL in microemulsions with trans-anethole or menthol. Additionally, mixtures (50/50 w/w) of Maxemul 6112 and Noigen RN-20 (non-ionic surfactant) with TPGS-1000 were also tested to prepare the microemulsions. ., l3b, 14b, 15b, 16b, 17b, 1 9b, 20b, 21 b, 22b, 
Proliferation Cell Assay
Balb 3T3 were cultured in DMEM F12-HAM medium containing 10% FBS and 1% penicillin (10,000 units/mL)/ streptomycin (10,000 ug/ml.) solution, and HeLa cells were cultured in RPMI 1640 medium supplemented with 10% FBS and 1 % antibiotics solution. Both cell lines were seeded in 96-well plates at a density of 200,000 cells/mL (100 µL) in RPMI 1640 without folic acid and supplemented with 10% FBS and 1 % antibiotics solution, and incubated for 24 hours at 37°C, 5% CO 2 and 90% relative humidity. Aliquots of microemulsions (100 µL) were added to each well. Plates were incubated during 24 and 48 hours. All experiments were carried out in triplicate.
Components of the microemulsions were separately dispersed phosphate buffered saline (PBS, SigmaAldrich) and tested at the same concentration as in the formulations. To do that, 2 µl of component dispersion was added to each well and incubated as indicated above. After 24 and 48 h of exposition, cell proliferation was measured using a MTT Kit (Roche, Gennany), following the manufacturer instructions. Absorbance was measured at a wavelength of 550 nm using an ELISA plate reader (BJORAD Model 680 Microplate Reader, USA).
Results and Discussion
Preparation of microemulsions
Several essential oils were investigated for the preparation of MTX-loaded o/w microemulsions. Peppermint oil (having menthol as main component) has been tested in the preparation of microemulsions [83, 84] loaded with celecoxib [85] or other anti-inflammatory drugs such as aceclofenac and diclofenac [86] . On the other hand, trans-anethole (1-methoxy-4-(l E)-1-propenylbenzene) is the major component (>99 %) of the naturally occurring essential oils of fennel and star anise, and is also present in dill, basil, and tarragon plants. It is widely used as an aniseed flavoring agent in a variety of confectioneries and beverages. Also, it has been used as an important ingredient of herbal medicines for centuries. Further, it has been shown that 1 mM trans-anethole causes death of MCF-7 human breast cancer cells after three days exposition [87] . Just recently, liposomal formulations of trans-anethole have been reported to be eight to nine times more cytotoxic than free trans-anethole in T47D and MCF-7 breast cancer cell lines. Therefore, the use of trans-anethole as oil carrier of antineoplastic agents may strengthen the cytotoxic effects. Finally, a -tocopherol and its derivatives have been pointed out to also have antitumor and antiinflammatory activity [88] .
TPGS-1000 is a biocompatible surfactant widely used as solubilizer and emulsifier. It may provide microemulsion droplets with prolonged circulation half-life and improved tumor accumulation, as previously observed for related surfactants such as distearoylphosphatidylethanolamine (DSPE)-PEG 2000 or 5000 [89] . Furthermore, it has been reported that TPGS inhibits P-glycoprotein efflux pump increasing oral absorption and cell accumulation of a variety of drugs, including antitumoral drugs [90] [91] [92] . Other surfactant tested was Maxemul 6112, an anionic phosphate ester (oleyl alcohol ethoxylate phosphate, concentration between 50 and 100 % w/w) with a polymerizable double bond in its main hydrocarbon chain, which may allow to form a stimuli responsive polymeric shell coating the drugloaded oleic core. Similarly Noigen RN-20 (polyoxyethylene 4-nonyl-2-propylene-phenol) is a nonionic polymerizable surfactant (HLB 15.4), which has been previously shown useful for the stabilization of non-aqueous emulsions [93] .
As a first step, the phase diagrams of ternary systems combining each essential oil, water and a mixture of TPGS-1000 (surfactant) and isobutanol (co-surfactant) were obtained (Fig. 3) . For the three essential oils tested, proportions of surfactant and co-surfactant above 10% were required. Microemulsions with peppermint oil (menthol) only formed when the oil was at very low proportion, which may represent a limitation for the incorporation of hydrophobic drugs. Microemulsions prepared with the compositions disclosed in Table 3 were proven to be transparent and homogeneous. Drug-loaded formulations were yellow due to drug color. Fig. (3) . Partial phase diagrams of ternary systems combining an essential oil, water and a mixture of TPGS-1000 (surfactant) and isobutanol (iso-BuOH, co-surfactant).
Proliferation Cell Assay
Microemulsions were tested regarding cytocompatibility using murine fibroblasts (Balb 3T3 cells), and regarding bioactivity using adenocarnicoma cells (HeLa cells) (Fig. 4) . In the case of fibroblast cells, drug loaded and non-loaded microemulsions prepared with a -tocopherol significantly increased cell proliferation, both in the tests carried out with 100 µl of microemulsion. Formulations with menthol and trans-anethole proved to be less cytocompatible, as expected from the previously reported data about cytotoxicity of these essential oils [87] . No relevant differences were observed between microemulsions with and without MTX. As observed with fibroblast cells, microemulsions were bioactive against tumor cells except those prepared with α-tocopherol. Interestingly, menthol and trans-anethole microemulsions led to similar cytotoxicity leve\s. Table 3 ). Blue, yellow and red bars identify microemulsions baving mentbol, α-tocopherol or trans-anethole as oily pbase, respectively.
To gain further insight into the origin of the cytotoxic effects of the microemulsions, each component was tested in separate at the same concentration as it is present in the formulations. Isolated surfactants, particularly TPGS and Maxemul, were found to be extreme\y toxic for both fibroblasts and tumor cells (Fig. 5) . It is known that surfactants exhibit concentration-dependent effects on cell viability and, in the absence of oils, TPGS and Maxemul unimers and micelles can readily interact with cell membranes and intracellular enzymes [94] . According to the suppliers, the oral LD 50 (for rats) values of TPGS-I000, Maxemul 6112 and Noigen RN-20 are >7000, 1530 and 2500 mg/kg, respectively. Menthol and transanethole led to detrimental effects on fibroblast viability after 48 h of incubation, but these essential oils did not significantly alter the viability of tumor cells. As expected, n-tocopherol showed an excellent cytocompatibility with fibroblasts and tumor cells. The proliferative effect of n-tocopherol explains its capability to counteract the toxicity of the surfactants. 
Conclusions
Although the literature on microemulsions as carriers of antitumor agents is still incipient, recent papers have pointed out their suitability not only for topical or mucosal application but also for systemic delivery. Versatile preparation, high drug loading and droplet size adequate for drug targeting are the most relevant advantages of microemulsíons compared to other nanocarriers. However, concerns about the toxicity of the surfactants still prevent from the systemic use. The MTX formulation study points out that in addition to surfactants, the essential oils used as internal phase of o/w microemulsions may notably determine the cytocompatibility. Blank microemulsions prepared with menthol and trans-anethole inhibit cell proliferation as much as those loaded with methotrexate. By contrast, n-tocopherol leads to microemulsions that strongly promote proliferation of both fibroblasts and adenocarcinoma cells, being totally inadequate for cancer treatment. Therefore, much research is still required for identifying suitable oily components that enable a good balance between compatibility with healthy cells and growth inhibition of cancer cells.
